COVID-19 transmission dynamics underlying epidemic waves in Kenya.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
19 Nov 2021
Historique:
pubmed: 8 10 2021
medline: 30 11 2021
entrez: 7 10 2021
Statut: ppublish

Résumé

Policy decisions on COVID-19 interventions should be informed by a local, regional and national understanding of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Epidemic waves may result when restrictions are lifted or poorly adhered to, variants with new phenotypic properties successfully invade, or infection spreads to susceptible subpopulations. Three COVID-19 epidemic waves have been observed in Kenya. Using a mechanistic mathematical model, we explain the first two distinct waves by differences in contact rates in high and low social-economic groups, and the third wave by the introduction of higher-transmissibility variants. Reopening schools led to a minor increase in transmission between the second and third waves. Socioeconomic and urban–rural population structure are critical determinants of viral transmission in Kenya.

Identifiants

pubmed: 34618602
doi: 10.1126/science.abk0414
pmc: PMC7612211
mid: EMS140736
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-994

Subventions

Organisme : Wellcome Trust
ID : 203077
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 107568
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220991
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 220985
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201866
Pays : United Kingdom

Références

Nature. 2021 Apr;592(7854):438-443
pubmed: 33690265
PLoS Comput Biol. 2021 Jan 22;17(1):e1008619
pubmed: 33481773
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Science. 2020 May 8;368(6491):
pubmed: 32234805
Lancet Respir Med. 2021 Feb;9(2):e20-e21
pubmed: 33417829
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Science. 2020 Jul 17;369(6501):315-319
pubmed: 32423996
Science. 2020 May 22;368(6493):860-868
pubmed: 32291278
Phys Rev Lett. 2021 Mar 19;126(11):118301
pubmed: 33798363
Elife. 2020 Jun 22;9:
pubmed: 32568070
Int J Infect Dis. 2021 Nov;112:25-34
pubmed: 34481966
BMC Infect Dis. 2021 Aug 30;21(1):889
pubmed: 34461847
Proc Biol Sci. 2007 Feb 22;274(1609):599-604
pubmed: 17476782
JAMA Intern Med. 2021 Oct 1;181(10):1407-1408
pubmed: 34048531
Nature. 2021 Jan;589(7840):82-87
pubmed: 33171481
Lancet Child Adolesc Health. 2020 Nov;4(11):817-827
pubmed: 32758453
Wellcome Open Res. 2021 May 25;6:127
pubmed: 36187498
Nat Med. 2021 Jul;27(7):1131-1133
pubmed: 34045737
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):9122-9126
pubmed: 32245814
Science. 2021 Jan 1;371(6524):79-82
pubmed: 33177105
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Science. 2021 Jan 15;371(6526):288-292
pubmed: 33293339
Clin Infect Dis. 2021 Aug 2;73(3):e699-e709
pubmed: 33400782
BMJ. 2020 Jul 1;370:m2516
pubmed: 32611558
Science. 2021 Oct 22;374(6566):423-431
pubmed: 34672751
BMC Health Serv Res. 2021 Jul 26;21(1):740
pubmed: 34311716
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
BMJ Glob Health. 2020 May;5(5):
pubmed: 32451367
Epidemics. 2019 Dec;29:100367
pubmed: 31591003
JAMA Intern Med. 2021 May 1;181(5):672-679
pubmed: 33625463
J Urban Health. 2020 Jun;97(3):348-357
pubmed: 32333243

Auteurs

Samuel P C Brand (SPC)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
The Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Warwick, UK.
School of Life Sciences, University of Warwick, Warwick, UK.

John Ojal (J)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
London School of Hygiene and Tropical Medicine (LSHTM), London, UK.

Rabia Aziza (R)

The Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Warwick, UK.
School of Life Sciences, University of Warwick, Warwick, UK.

Vincent Were (V)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.

Emelda A Okiro (EA)

Population Health Unit, Kenya Medical Research Institute-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Ivy K Kombe (IK)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Caroline Mburu (C)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Morris Ogero (M)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Ambrose Agweyu (A)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

George M Warimwe (GM)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

James Nyagwange (J)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Henry Karanja (H)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

John N Gitonga (JN)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Daisy Mugo (D)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Sophie Uyoga (S)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Ifedayo M O Adetifa (IMO)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

J Anthony G Scott (JAG)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Department of Infectious Diseases Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.

Edward Otieno (E)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Nickson Murunga (N)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Mark Otiende (M)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Lynette I Ochola-Oyier (LI)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Charles N Agoti (CN)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

George Githinji (G)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Kadondi Kasera (K)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Patrick Amoth (P)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Mercy Mwangangi (M)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Rashid Aman (R)

Ministry of Health, Government of Kenya, Nairobi, Kenya.

Wangari Ng'ang'a (W)

Presidential Policy and Strategy Unit, The Presidency, Government of Kenya.

Benjamin Tsofa (B)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.

Philip Bejon (P)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Matt J Keeling (MJ)

The Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Warwick, UK.
School of Life Sciences, University of Warwick, Warwick, UK.
Mathematics Institute, University of Warwick, Warwick, UK.

D James Nokes (DJ)

Kenya Medical Research Institute (KEMRI)-Wellcome Trust Research Programme (KWTRP), Kilifi, Kenya.
The Zeeman Institute for Systems Biology and Infectious Disease Epidemiology Research (SBIDER), University of Warwick, Warwick, UK.
School of Life Sciences, University of Warwick, Warwick, UK.

Edwine Barasa (E)

Health Economics Research Unit, KEMRI-Wellcome Trust Research Programme, Nairobi, Kenya.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH